English
Bulgarian
Chinese (Simplified)
Croatian
Czech
Danish
Dutch
Finnish
French
German
Greek
Hebrew
Hindi
Indonesian
Italian
Japanese
Korean
Macedonian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swedish
Thai
Turkish
Vietnamese
Prizes
The 2022 Goldman Prize is awarded to Professor Andreas Hochhaus
We are delighted to announce Professor Andreas Hochhaus, Head of the Department of Hematology and Medical Oncology at Jena University Hospital as the 2022 Goldman Prize recipient. He receives the prize in recognition of his outstanding clinical leadership in CML and for his lifelong contributions to the optimization of CML therapy – through his work on mechanisms of resistance and stem cell persistence, through leading clinical studies and through the development of clinical recommendations. The annual Goldman Prize awarded in honour of Professor John Goldman, acknowledges outstanding lifetime contributions to the management of patients with CML.
The 2022 Rowley Prize is awarded to Professor Oliver Hantschel
The iCMLf awards the 2022 Rowley Prize to Professor Oliver Hantschel, for his scientific research on structural biochemistry of tyrosine kinase oncoproteins that helped to describe novel targetable pathways in the pathophysiology of BCR-ABL. The Rowley Prize is awarded to celebrate people who have made outstanding lifetime contributions to the understanding of the biology of CML.
The 2022 iCMLf Prize is awarded to Giora Sharf and Jan Geissler
This year, the iCMLf Directors and Advisors have selected two powerful voices for patients with CML as recipients for the iCMLf Prize. Giora Sharf (Israel) and Jan Geissler (Germany) have used the experience of their own diagnosis to help other patients. They have tirelessly advocated for the needs of patients with CML across the world over the past decades. The iCMLf Prize recognizes outstanding contributions to the improvement of CML treatment in low- and middle-income countries. As giants in patient advocacy around the world, Jan and Giora are worthy recipients of this award.
The 2021 Rowley Prize is awarded to Professor Susan Branford
The iCMLf is pleased to announce Professor Susan Branford, SA Pathology and Centre for Cancer Biology in Adelaide as the 2021 Rowley Prize winner. This annual prize awarded by the International CML Foundation recognises outstanding contributions to the understanding of the biology of CML. Sue is a leading international authority on molecular monitoring for CML and a major contributor to international collaborative initiatives to establish guidelines and recommendations for producing reliable molecular data.
The 2021 Goldman Prize is awarded to Professor Giuseppe Saglio
We are delighted to announce that Professor Giuseppe Saglio, Professor of Haematology and Internal Medicine at the University of Turin (Italy) has been awarded the 2021 Goldman Prize. The annual Goldman Prize, awarded in honour of Professor John Goldman, acknowledges outstanding contributions to the management of patients with CML and Professor Saglio is universally regarded as one of the greatest experts in CML treatment.
The 2021 iCMLf Prize is awarded to Dr Damira Bayzakova from Kyrgyzstan
The iCMLf Directors and Advisors have selected Dr Damira Bayzakova, a pediatric oncologist from the National Center of Oncology in Bishkek (Kyrgyzstan) as the 2021 iCMLf Prize winner. Dr Bayzakova has been awarded the prize posthumously for her efforts that greatly improved the monitoring and treatment of CML in Kyrgyzstan and to recognize her work and legacy. The iCMLf Prize recognizes outstanding contributions to the improvement of CML under the challenging conditions of low- and middle-income countries with unequal access to monitoring and access.
“Dr. Bayzakova was a CML specialist from Kyrgyzstan who tragically passed away in November 2020, due to complications of COVID-19. She dedicated her life to her patients and through her efforts greatly improved the treatment of CML in her country.” Pat Garcia-Gonzales, CEO, The Max Foundation
